> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Generic Mifepristone Maker Wants to Defend Suit
- URL: https://www.fdaweb.com/generic-mifepristone-maker-wants-to-defend-suit/
- Published: 2025-02-26T12:00:00.000Z
- Updated: 2026-09-14T14:54:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158731

GenBioPro, which manufactures a generic form of the abortion medication mifepristone, has petitioned a Texas federal court to be added to the defendants in the first legal fight over the procedure since **Donald Trump** became president again. *The Hill* [reports](https://thehill.com/policy/healthcare/5165569-abortion-pill-maker-court-battle-fda/?ref=fdaweb.com) that *Missouri et. al. v FDA* is a revamped version of a 2023 suit filed by anti-abortion groups and doctors seeking to block FDA’s approval of the abortion drug.

The states that filed the suit want FDA to ban telehealth prescriptions for mifepristone, ban its use after seven weeks of pregnancy, and prevent pharmacies from dispensing it, the article says.

“We remain concerned about extremists and special interests’ attempts to undermine FDA’s regulatory authority,” GenBioPro CEO **Evan Masingill** said in a statement. FDA approved GenBioPro’s generic version in 2019.